Webinar Invitation | The Evolution of the Airline Industry in the Age of COVID-19 – 9/22 at 1:00 p.m. ET

From: Neuberger Berman <[email protected]>
Sent: September 16, 2020 12:15 PM
To: John Warrington <[email protected]>
Subject: Webinar Invitation | The Evolution of the Airline Industry in the Age of COVID-19 – 9/22 at 1:00 p.m. ET

‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Can’t view images? Click here

RESEARCH SECTOR SPOTLIGHT SERIES | WEBINAR INVITATION The Evolution of the Airline Industry in the Age of COVID-19 A Fireside Chat with Ed Bastian, CEO of Delta Air Lines Tuesday, September 22, 2020 | 1:00 – 2:00 p.m. ET Discussion REGISTER Please join us for our inaugural Research Sector Spotlight Series webinar, where we will be providing investors with an opportunity to hear directly from companies that are changing the world we live in. Our first conversation will feature a fireside chat between Ed Bastian, Chief Executive Officer of Delta Air Lines and Michael Barr, Senior Research Analyst, Neuberger Berman. Having led Delta through multiple periods of volatility, including out of bankruptcy post 9/11, Ed will provide his unique perspective on the impact of the COVID-19 pandemic, the evolution of the airline industry, and expectations for the future of global travel. Please RSVP by using the registration link above. SPEAKERS Ed Bastian Chief Executive Officer Delta Air Lines View Biography Michael Barr Senior Research Analyst Neuberger Berman View Biography About the Neuberger Berman Research Sector Spotlight Series: In our Research Sector Spotlight Series, our Senior Research Analysts will moderate a series of virtual discussions with leading CEOs and executives in sectors where the impact of COVID-19 was highest. Join the conversation as they discuss valuable insights on how the pandemic impacted their businesses both positively and negatively, and hear their outlooks for the future of their industries. Save the date and stay tuned for more details on Neuberger Berman’s upcoming Research Sector Spotlight events in the coming months. – Tuesday, September 22 – Delta Air Lines – Wednesday, October 7 – CardFlight – Thursday, October 15 – Peloton This material is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice. This material is general in nature and is not directed to any category of investors and should not be regarded as individualized, a recommendation, investment advice or a suggestion to engage in or refrain from any investment-related course of action. Investment decisions and the appropriateness of this material should be made based on an investor’s individual objectives and circumstances and in consultation with his or her advisors. Any views or opinions expressed may not reflect those of the firm as a whole. This material may include estimates, outlooks, projections and other “forward-looking statements.” Due to a variety of factors, actual events may differ significantly from those presented. Neuberger Berman products and services may not be available in all jurisdictions or to all client types. Diversification does not guarantee profit or protect against loss in declining markets. Investing entails risks, including possible loss of principal. Past performance is no guarantee of future results. Discussions of any specific sectors and companies are for informational purposes only. This material is not intended as a formal research report and should not be relied upon as a basis for making an investment decision. The firm, its employees and advisory accounts may hold positions of any companies discussed. Nothing herein constitutes a recommendation to buy, sell or hold a security. Specific securities identified and described do not represent all of the securities purchased, sold or recommended for advisory clients. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. The views of the research analyst and the firm and its employees on medical topics should not be relied upon as medical advice and are not intended to serve as a substitute for consulting with a qualified medical professional. There is no representation or warranty as to its accuracy, completeness or reliability. All information is current as of the date of the material and is subject to change without notice. The firm, its employees and advisory accounts may hold positions of the manufacturers of the products discussed. For more information on COVID-19, please refer to the Center for Disease Control and Prevention at cdc.gov This material is being issued on a limited basis through various global subsidiaries and affiliates of Neuberger Berman Group LLC. Please visit www.nb.com/disclosure-global-communications for the specific entities and jurisdictional limitations and restrictions. The “Neuberger Berman” name and logo are registered service marks of Neuberger Berman Group LLC. © 2020 Neuberger Berman Group LLC. All rights reserved.